1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Evoked potentials - Neuro-electric responses to sensory stimuli

Discussion in 'Laboratory and genetic testing, medical imaging' started by CRG, Oct 7, 2022.

  1. CRG

    CRG Senior Member (Voting Rights)

    Messages:
    1,857
    Location:
    UK
    Copied post

    Perhaps a distraction as Cognitive status isn't included in the above list, but Evoked Potentials if relevant to ME/CFS offer a possibility of providing objective measurement of neurological change, which to date hass only been explored in limited studies*.

    The clinical role of evoked potentials
    P Walsh, N Kane, S Butler 2005

    "Neuro-electric responses to sensory stimuli can be readily and non-invasively recorded using averaging techniques first employed by Dawson in 1947.1 The evoked responses can be quantified by measuring peak amplitudes and latencies, in the millisecond (ms) domain, and they provide numerical data that are quantitative extensions of the neurological examination. The clinical utility of evoked potentials (EPs) is based on their ability to:
    • demonstrate abnormal sensory system conduction, when the history and/or neurological examination is equivocal

    • reveal subclinical involvement of a sensory system (“silent” lesions), particularly when demyelination is suggested by symptoms and/or signs in another area of the central nervous system

    • help define the anatomic distribution and give some insight into pathophysiology of a disease process

    • monitor changes in a patient’s neurological status.
    In theory almost any sensory modality may be tested, although in routine clinical practice pattern reversal visual evoked potentials (VEPs), short latency somatosensory evoked potentials (SSEPs), and brainstem auditory evoked potentials (BSAEPs) are tested most frequently. Longer latency responses that are related to higher “cognitive” functions such as event related potentials (ERPs), contingent negative variant (CNV), and sensory potentials after stimulation with CO2 lasers are not routinely used in clinical practice and are beyond the scope of this article.

    EPs have the advantages of being objective, often more sensitive than detailed neurological examination, and they can be recorded in patients who are anaesthetised or comatose. The latter fact, along with improvements in recording equipment, has led to newer applications in the operating theatre and intensive care unit (ICU)—at a time when the role of EPs in the assessment of multiple sclerosis has largely been replaced by magnetic resonance imaging (MRI).

    A recent evidence based review recommended that VEPs are probably useful and SSEPs are possibly useful in identifying patients who are at increased risk for developing clinically definite MS, but that there was insufficient evidence to recommend BSAEPs.2

    Disadvantages of EPs in clinical practice are that they are rarely disease specific and can be confounded by end organ disease (for example, VEPs may be abnormal in ocular disease, SSEPs in patients with peripheral neuropathy, and BSAEPs in conductive and sensorineural deafness), are affected by age, and require a degree of patient cooperation to obtain artefact-free recordings."

    Full article: https://jnnp.bmj.com/content/76/suppl_2/ii16

    * Studies into CFS using evoked potentials

    Event-related potentials in Japanese childhood chronic fatigue syndrome
    Attention and short‐term memory in chronic fatigue syndrome patients
    Cognitive impairment in fatigue and sleepiness associated conditions
    Decreased postexercise facilitation of motor evoked potentials in patients with chronic fatigue syndrome or depression
     
    Last edited by a moderator: Jan 29, 2023
    Hutan likes this.

Share This Page